TYP
Click for more information
10.5% 2.1¢ tryptamine therapeutics limited

News: EX1 Exopharm Says Ian Dixon's Employment As CEO Expected To End In Early 2024

  1. Hot News
    190,080 Posts.
    lightbulb Created with Sketch. 2787
    clock Created with Sketch.
    28/11/23
    12:00
    Post #: 71143339

    Nov 28 (Reuters) - Exopharm Ltd (EX1) :

    • IAN DIXON EMPLOYMENT AS CEO IS EXPECTED TO END IN EARLY CY 24.
    • IS MINIMISING NON- ESSENTIAL COSTS
    • WORKING TO BRING POTENTIAL TRANSACTION TO SHAREHOLDERS AND HAVE COMPANY'S SHARES RECOMMENCE TRADING
    • DETERMINED THAT A FULL-TIME CEO ROLE WILL NOT BE REQUIRED GOING FORWARD
    • SEEKING A TRANSACTION THAT COULD RESULT IN A MATERIAL CHANGE IN COMPANY'S ACTIVITIES
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.002(10.5%) 		Mkt cap ! $22.87M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $27.87K 1.464M

Buyers (Bids)

No. Vol. Price($)
2 527780 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 613000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.